Literature DB >> 15294329

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

Rahyeong Juh1, Jaesung Kim, Daehyuk Moon, Boyoung Choe, Tasuk Suh.   

Abstract

Idiopathic Parkinson's disease (IPD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are the most common movement disorders associated with neurodegenerative disease. A clinical differential diagnosis of IPD and atypical Parkinsonian disorders, such as MSA and PSP, is often complicated by the presence of symptoms common to both groups. Since Parkinsonism has a different pathophysiology in the cortical and subcortical brain structures, assessing the regional cerebral glucose metabolism may assist in making a differential diagnosis of Parkinsonism. The 18F-FDG PET images of IPD, MSA and PSP were assessed using statistical parametric mapping (SPM) in order to determine the useful metabolic patterns. Twenty-four patients with Parkinsonism: eight patients (mean age 67.9 +/- 10.7 years; M/F: 3/5) with IPD, nine patients (57.9 +/- 9.2 years; M/F: 4/5) with MSA and seven patients (67.6 +/- 4.8 years; M/F: 3/4) with PSP were enrolled in this study. All patients with Parkinsonism and 22 age-matched normal controls underwent 18F-FDG PET, (after 370 MBq 18F-FDG). The three groups and the individual IPD, MSA and PSP patients were compared with a normal control group using a two-sided t-test of SPM (uncorrected P < 0.01, extent threshold > 100 voxel). The IPD, MSA and PSP groups showed significant hypometabolism in the cerebral neocortex compared to the normal control group. The MSA group showed significant hypometabolism in the putamen, pons and cerebellum compared to the normal controls and IPD groups. In addition, PSP showed significant hypometabolism in the caudate nucleus, the thalamus, midbrain and the cingulate gyrus compared to the normal controls, the IPD and the MSA groups. In conclusion, an assessment of the 18F-FDG PET images using SPM may be a useful adjunct to a clinical examination when making a differential diagnosis of Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294329     DOI: 10.1016/S0720-048X(03)00214-6

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  35 in total

1.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.

Authors:  Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03       Impact factor: 9.236

2.  Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.

Authors:  Ji Hyun Ko; Chong Sik Lee; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

3.  Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.

Authors:  Andrea Varrone; Marco Pagani; Elena Salvatore; Dario Salmaso; Valeria Sansone; Marianna Amboni; Flavio Nobili; Giuseppe De Michele; Alessandro Filla; Paolo Barone; Sabina Pappatà; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-24       Impact factor: 9.236

4.  Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.

Authors:  Petra Tomše; Luka Jensterle; Marko Grmek; Katja Zaletel; Zvezdan Pirtošek; Vijay Dhawan; Shichun Peng; David Eidelberg; Yilong Ma; Maja Trošt
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

Review 5.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

6.  Comparison of the Performances of (18)F-FP-CIT Brain PET/MR and Simultaneous PET/CT: a Preliminary Study.

Authors:  SangDon Kwon; KyungAh Chun; EunJung Kong; IhnHo Cho
Journal:  Nucl Med Mol Imaging       Date:  2016-05-06

7.  FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.

Authors:  Nicholas Zalewski; Hugo Botha; Jennifer L Whitwell; Val Lowe; Dennis W Dickson; Keith A Josephs
Journal:  J Neurol       Date:  2014-02-04       Impact factor: 4.849

8.  Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.

Authors:  Soyoung Jin; Minyoung Oh; Seung Jun Oh; Jungsu S Oh; Sang Ju Lee; Sun Ju Chung; Chong Sik Lee; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-11-03

9.  Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.

Authors:  S Hesse; C Oehlwein; H Barthel; J Schwarz; D Polster; A Wagner; O Sabri
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

Review 10.  [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].

Authors:  P T Meyer; F Amtage; S Hellwig
Journal:  Nervenarzt       Date:  2014-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.